NASDAQ:CADX - Cadence Pharmaceuticals Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseN/AToday's RangeN/A52-Week RangeN/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cadence Pharmaceuticals, Inc. (Cadence) is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing products principally for use in the hospital setting. The Company has rights to one product, OFIRMEV (acetaminophen) injection, an intravenous (IV), formulation of acetaminophen. The Company in-licensed the United States, and Canadian rights to OFIRMEV from Bristol-Myers Squibb Company (BMS), which sells intravenous acetaminophen in Europe and other markets for the treatment of acute pain and fever under the brand name Perfalgan. In March 2014, Mallinckrodt Plc acquired Cadence Pharmaceuticals, Inc. In March 2014, Mallinckrodt Plc completed the acquisition of Cadence Pharmaceuticals. Receive CADX News and Ratings via Email Sign-up to receive the latest news and ratings for CADX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryPharmaceuticals SectorN/A Current SymbolNASDAQ:CADX Previous Symbol CUSIP12738T10 CIK1333248 Webwww.cadencepharm.com Phone+1-858-4361400Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Cadence Pharmaceuticals (NASDAQ:CADX) Frequently Asked Questions What is Cadence Pharmaceuticals' stock symbol? Cadence Pharmaceuticals trades on the NASDAQ under the ticker symbol "CADX." Has Cadence Pharmaceuticals been receiving favorable news coverage? Headlines about CADX stock have trended positive on Monday, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Cadence Pharmaceuticals earned a daily sentiment score of 3.0 on InfoTrie's scale. They also assigned headlines about the biopharmaceutical company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the next several days. What other stocks do shareholders of Cadence Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cadence Pharmaceuticals investors own include China New Borun (BORN), Zagg (ZAGG), Urban One (UONEK), Oclaro (OCLR), Identiv (INVE), Immunomedics (IMMU), Forward Industries (FORD), Neuralstem (CUR), Ballard Power Systems (BLDP) and Arca Biopharma (ABIO). How do I buy shares of Cadence Pharmaceuticals? Shares of CADX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Cadence Pharmaceuticals' official website? The official website for Cadence Pharmaceuticals is http://www.cadencepharm.com. How can I contact Cadence Pharmaceuticals? Cadence Pharmaceuticals' mailing address is 12481 High Bluff Dr Ste 200, SAN DIEGO, CA 92130-3583, United States. The biopharmaceutical company can be reached via phone at +1-858-4361400. MarketBeat Community Rating for Cadence Pharmaceuticals (NASDAQ CADX)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 143 (Vote Outperform)Underperform Votes: 169 (Vote Underperform)Total Votes: 312MarketBeat's community ratings are surveys of what our community members think about Cadence Pharmaceuticals and other stocks. Vote "Outperform" if you believe CADX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CADX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/25/2019 by MarketBeat.com StaffFeatured Article: Why does a company issue an IPO?